
|Articles|April 23, 2019
Top 5 Key Takeaways from ECCMID 2019
Author(s)Contagion® Editorial Staff
Here are the top takeaways from the European Congress of Clinical Microbiology and Infectious Disease 2019 meeting.
Advertisement
Read more about these stories:
- FURI Study Case: Ibrexafungerp Successfully Treats Esophageal Candidiasis
- CAMERA2: Combination Therapy for MRSA Bacteremia Effective but Linked to Higher Mortality, AKI Rates
- Most Patients With UTI Symptoms Receive Antibiotics, Yet Lack Evidence of Infection
- Jose Arribas, MD, on the Challenges That Come With Long-Acting Injectables
- ASPECT-NP: Ceftolozane/Tazobactam Efficacious for Ventilated Nosocomial Pneumonia
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
CDC's Latest Hepatitis B Vaccine Guidance Serves as Example for Future Federal Vaccine Policy
2
Growing International Evidence Suggests Emerging Metallo-β-Lactamase Therapy Could Benefit US Clinicians
3
Addressing the Three Pillars of PPE in Caring for Patients with High-Consequence Infectious Disease
4
Antibiotic De-Escalation Demonstrates Advantages for Community-Onset Sepsis
5































































































































































































































































































































